Literature DB >> 21737533

Orphans in the human cytochrome P450 superfamily: approaches to discovering functions and relevance in pharmacology.

F Peter Guengerich1, Qian Cheng.   

Abstract

As a result of technical advances in recombinant DNA technology and nucleotide sequencing, entire genome sequences have become available in the past decade and offer potential in understanding diseases. However, a central problem in the biochemical sciences is that the functions of only a fraction of the genes/proteins are known, and this is also an issue in pharmacology. This review is focused on issues related to the functions of cytochrome P450 (P450) enzymes. P450 functions can be categorized in several groups: 1) Some P450s have critical roles in the metabolism of endogenous substrates (e.g., sterols and fat-soluble vitamins). 2) Some P450s are not generally critical to normal physiology but function in relatively nonselective protection from the many xenobiotic chemicals to which mammals (including humans) are exposed in their diets [as well as more anthropomorphic chemicals (e.g., drugs, pesticides)]. 3) Some P450s have not been extensively studied and are termed "orphans" here. With regard to elucidation of any physiological functions of the orphan P450s, the major subject of this review, it is clear that simple trial-and-error approaches with individual substrate candidates will not be very productive in addressing questions about function. A series of liquid chromatography/mass spectrometry/informatics approaches are discussed, along with some successes with both human and bacterial P450s. Current information on what are still considered "orphan" P450s is presented. The potential for application of some of these approaches to other enzyme systems is also discussed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21737533      PMCID: PMC3141877          DOI: 10.1124/pr.110.003525

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN: 0031-6997            Impact factor:   25.468


  97 in total

1.  Molecular 'pharming' with plant P450s.

Authors:  J M Humphreys; C Chapple
Journal:  Trends Plant Sci       Date:  2000-07       Impact factor: 18.313

2.  Differential regulation of human CYP4A genes by peroxisome proliferators and dexamethasone.

Authors:  Uzen Savas; Mei-Hui Hsu; Eric F Johnson
Journal:  Arch Biochem Biophys       Date:  2003-01-01       Impact factor: 4.013

Review 3.  Plant cytochromes P450: tools for pharmacology, plant protection and phytoremediation.

Authors:  Marc Morant; Søren Bak; Birger Lindberg Møller; Danièle Werck-Reichhart
Journal:  Curr Opin Biotechnol       Date:  2003-04       Impact factor: 9.740

4.  Untargeted analysis of mass spectrometry data for elucidation of metabolites and function of enzymes.

Authors:  Raymundo Sanchez-Ponce; F Peter Guengerich
Journal:  Anal Chem       Date:  2007-04-05       Impact factor: 6.986

5.  Mutations in a new cytochrome P450 gene in lamellar ichthyosis type 3.

Authors:  Caroline Lefèvre; Bakar Bouadjar; Véronique Ferrand; Gianluca Tadini; André Mégarbané; Mark Lathrop; Jean-François Prud'homme; Judith Fischer
Journal:  Hum Mol Genet       Date:  2006-01-25       Impact factor: 6.150

Review 6.  Evolution of the P450 gene superfamily: animal-plant 'warfare', molecular drive and human genetic differences in drug oxidation.

Authors:  F J Gonzalez; D W Nebert
Journal:  Trends Genet       Date:  1990-06       Impact factor: 11.639

7.  Cytochrome P450 2S1 is reduced by NADPH-cytochrome P450 reductase.

Authors:  Yi Xiao; Raku Shinkyo; F Peter Guengerich
Journal:  Drug Metab Dispos       Date:  2011-03-23       Impact factor: 3.922

8.  Human CYP2S1 metabolizes cyclooxygenase- and lipoxygenase-derived eicosanoids.

Authors:  Peter Bui; Satoshi Imaizumi; Sudheer Reddy Beedanagari; Srinivasa T Reddy; Oliver Hankinson
Journal:  Drug Metab Dispos       Date:  2010-11-10       Impact factor: 3.922

9.  Human cytochrome P450 4F11: heterologous expression in bacteria, purification, and characterization of catalytic function.

Authors:  Zhongmei Tang; Sandra Giovanna Salamanca-Pinzón; Zhong-Liu Wu; Yi Xiao; F Peter Guengerich
Journal:  Arch Biochem Biophys       Date:  2009-11-20       Impact factor: 4.013

10.  Bietti crystalline corneoretinal dystrophy is caused by mutations in the novel gene CYP4V2.

Authors:  Anren Li; Xiaodong Jiao; Francis L Munier; Daniel F Schorderet; Wenliang Yao; Fumino Iwata; Mutsuko Hayakawa; Atsushi Kanai; Muh Shy Chen; Richard Alan Lewis; John Heckenlively; Richard G Weleber; Elias I Traboulsi; Qingjiong Zhang; Xueshan Xiao; Muriel Kaiser-Kupfer; Yuri V Sergeev; J Fielding Hejtmancik
Journal:  Am J Hum Genet       Date:  2004-03-23       Impact factor: 11.025

View more
  44 in total

Review 1.  Contributions of human enzymes in carcinogen metabolism.

Authors:  Slobodan Rendic; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2012-05-10       Impact factor: 3.739

2.  Oxidation of dihydrotestosterone by human cytochromes P450 19A1 and 3A4.

Authors:  Qian Cheng; Christal D Sohl; Francis K Yoshimoto; F Peter Guengerich
Journal:  J Biol Chem       Date:  2012-07-07       Impact factor: 5.157

Review 3.  Cytochrome P450 2U1, a very peculiar member of the human P450s family.

Authors:  L Dhers; L Ducassou; J-L Boucher; D Mansuy
Journal:  Cell Mol Life Sci       Date:  2017-01-12       Impact factor: 9.261

4.  Metabolomic analysis and identification of a role for the orphan human cytochrome P450 2W1 in selective oxidation of lysophospholipids.

Authors:  Yi Xiao; F Peter Guengerich
Journal:  J Lipid Res       Date:  2012-05-16       Impact factor: 5.922

5.  A fluorescent microplate assay quantifies bacterial efflux and demonstrates two distinct compound binding sites in AcrB.

Authors:  Ramkumar Iyer; Annette Ferrari; R Rijnbrand; Alice L Erwin
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

Review 6.  Eicosanoids in metabolic syndrome.

Authors:  James P Hardwick; Katie Eckman; Yoon Kwang Lee; Mohamed A Abdelmegeed; Andrew Esterle; William M Chilian; John Y Chiang; Byoung-Joon Song
Journal:  Adv Pharmacol       Date:  2013

7.  Human mitochondrial cytochrome P450 27C1 is localized in skin and preferentially desaturates trans-retinol to 3,4-dehydroretinol.

Authors:  Kevin M Johnson; Thanh T N Phan; Matthew E Albertolle; F Peter Guengerich
Journal:  J Biol Chem       Date:  2017-07-12       Impact factor: 5.157

8.  Oxidation of endogenous N-arachidonoylserotonin by human cytochrome P450 2U1.

Authors:  Michal Siller; Sandeep Goyal; Francis K Yoshimoto; Yi Xiao; Shouzou Wei; F Peter Guengerich
Journal:  J Biol Chem       Date:  2014-02-21       Impact factor: 5.157

Review 9.  Human cytochrome P450 enzymes 5-51 as targets of drugs and natural and environmental compounds: mechanisms, induction, and inhibition - toxic effects and benefits.

Authors:  Slobodan P Rendic; F Peter Guengerich
Journal:  Drug Metab Rev       Date:  2018-08       Impact factor: 4.518

10.  Bioactivation of fluorinated 2-aryl-benzothiazole antitumor molecules by human cytochrome P450s 1A1 and 2W1 and deactivation by cytochrome P450 2S1.

Authors:  Kai Wang; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2012-07-10       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.